Pharmaceutical combinations and their use The present disclosure relates to a pharmaceutical combination, e.g. a product, comprising a combination of CGM097 and nilotinib, or a pharmaceutically acceptable salt thereof, respectively, which are jointly active in the treatment of proliferative diseases. The disclosure also relates to corresponding pharmaceutical formulations, uses, methods, combinations, data carrier and related disclosure embodiments.
